Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin Lead ...

AMGN has a strong balance sheet with a BBB+ credit rating from S&P. This is supported by $8.8 billion in cash on hand and a ...

Nu-Tek BioSciences announces attendance at SIMB 2025. Visit Booth 18 to learn more about the company's animal-free yeast and ...

Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a ...